What is the current Price Target for the Anebulo Pharmaceuticals Inc stock?

The average Anebulo Pharmaceuticals Inc target price is $5.50. This is 444.50% higher than the current stock price. The highest price target is 692.00%, the lowest is 197.00%. 2 Analysts have issued a price target Anebulo Pharmaceuticals Inc 2026 .

How high will the Anebulo Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the Anebulo Pharmaceuticals Inc stock will rise. The performance of stocks, including the Anebulo Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Anebulo Pharmaceuticals Inc stock today?

The performance of Anebulo Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Anebulo Pharmaceuticals Inc stock fall?

The decline in Anebulo Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Anebulo Pharmaceuticals Inc Forecast, price target & analysts

$1.01

4.71% yesterday

Nasdaq, May 20, 10:00 pm CET

ISIN

US0345691036

Symbol

ANEB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Anebulo Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

Anebulo Pharmaceuticals Inc Classifications & Recommendation:

Buy

100%

Anebulo Pharmaceuticals Inc Price Target

Target Price	$5.50
Price	$1.01
Potential	444.50% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Anebulo Pharmaceuticals Inc 2026 . The average Anebulo Pharmaceuticals Inc target price is $5.50. This is 444.50% register free of charge higher than the current stock price. The highest price target is $8.00 692.00% register free of charge , the lowest is $3.00 197.00% register free of charge .
	A rating was issued by 2 analysts: 2 Analysts recommend Anebulo Pharmaceuticals Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Anebulo Pharmaceuticals Inc stock has an average upside potential 2026 of 444.50% register free of charge . Most analysts recommend the Anebulo Pharmaceuticals Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Jun '24	2025 Estimates
Earnings Per Share $	-0.32	-0.32
	31.91%	0.00%
P/E		negative

1 Analysts have issued a Anebulo Pharmaceuticals Inc forecast for earnings per share. The average Anebulo Pharmaceuticals Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.32	31.91%
2025	$-0.32 0.00% Unlock
2026	$-0.48 50.00% Unlock
2027	$-0.46 4.17% Unlock
2028	$-0.49 6.52% Unlock
2029	$-0.54 10.20% Unlock

Current	-3.77	40.44%
2025	-3.16 16.18% Unlock
2026	-2.10 33.54% Unlock
2027	-2.20 4.76% Unlock
2028	-2.06 6.36% Unlock
2029	-1.87 9.22% Unlock

Anebulo Pharmaceuticals Inc...

Current Anebulo Pharmaceuticals Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Maxim Group	Locked ➜ Locked	Locked	May 15 2025
Benchmark	Locked ➜ Locked	Locked	Nov 19 2024
Benchmark	Locked ➜ Locked	Locked	Oct 01 2024

Analyst Rating	Date
Locked Maxim Group: Locked ➜ Locked	May 15 2025
Locked Benchmark: Locked ➜ Locked	Nov 19 2024
Locked Benchmark: Locked ➜ Locked	Oct 01 2024

Discover more stocks with a high price target

BioNTech SE - ADR 32.27%

Alibaba Group Holding Ltd 29.91%

Tencent Holdings Ltd. 22.81%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now